Skanska is building a pharmaceutical manufacturing plant in Woburn, Massachusetts, USA for $ 125 million, or approximately SEK 1.1 billion

0

[ad_1]

STERSUND, Sweden, 22 December 2021 / PRNewswire / – Skanska has signed a contract with Continuus Pharmaceuticals for the construction of a pharmaceutical manufacturing plant in Woburn, Massachusetts, UNITED STATES. The contract is worth $ 125 million, on 1.1 billion Swedish kronor, which will be included in the US order books for the fourth quarter of 2021.

The contract includes the renovation and construction of a new 50,000 square foot (approximately 4,500 square meters) cGMP manufacturing facility in an existing hull space. The new facility will produce both dry active pharmaceutical ingredients (API) and finished pharmaceutical products (DP) in sterile injectable and tablet form. The facility is being developed to produce three critical care drugs and an additional key drug with flexibility for future growth.

The contract also includes extensive support utility equipment and a new penthouse and new utility structure on the third floor. The existing roof will be raised to allow for additional equipment support areas and API manufacturing heights, as well as a new bracing system installed on the existing roof, which will support the modular air handling unit penthouse. .

Construction activities for the project started in October 2021 and are expected to be completed in the second quarter of 2022.

Skanska is one of the leading construction and project development companies in the United States, specializing in the construction of buildings, civil infrastructure and the development of commercial properties in select American markets. Skanska United States had sales of 66 billion Swedish kronor in 2020 and had approximately 7,600 employees in its operations.

For more information, please contact:

Brittany Felteau, Director of Communications, Skanska United States, phone +1 617 574 14 85

Jacob Birkeland, Head of Media Relations and Public Affairs, Skanska AB,
tel +46 (0) 10 449 04 94, direct media line, tel +46 (0) 10 448 88 99

This version and previous versions are also available at www.skanska.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skanska/r/skanska-builds-pharmaceutical-manufacturing-facility-in-woburn–massachusetts–usa–for-usd-125m–ab,c3476703

The following files are available for download:

SOURCE Skanska

[ad_2]
Source link

Share.

Comments are closed.